Archean Chemical announces its Annual General Meeting on June 12, 2026, conducted via video conferencing. The meeting aims to approve financials, distribute a dividend of ₹2.50 per share, and reappoint directors and auditors.

Archean Chemicals saw a 7.2% decrease in Q4 industrial salt volumes, but managed a 22% increase for the full year. Despite a 4% rise in bromine volume, higher costs impacted Q4 margins, leading to plans for brine field expansion.

Archean Chemical Industries reports a 9% drop in Q4 FY26 revenue to ₹304.7 crore, attributed to logistical and pricing issues. Profit After Tax (PAT) decreased by 34.3%. Despite these challenges, the company aims for a 15% growth in bromine production next year, with higher logistics costs of around ₹14-15 crore due to recent changes in routes and fuel prices.

Despite encountering some obstacles, Archean Chemical Industries successfully increased its revenue by 3% in the fiscal year 2026, a testament to their ongoing efforts to stimulate growth through expansion strategies.

Archean Chemical Industries proposes a final dividend of INR 2.50 per share for FY26, pending approval at the AGM. The stock ended the day at INR 596.90 on BSE, marking a decline from its previous close of INR 623.65, with a turnover of approximately INR 1.18 crore and 19,844 shares traded.

Archean Chemical's subsidiary, SiCSem, has committed a substantial $28 billion INR for semiconductor production under India's Semicon Programme. This investment aims to manufacture 60,000 Silicon Carbide (SiC) wafers and 96 million MOSFETs annually.

Archean Chem's Q4 earnings show a significant drop, with net sales decreasing by 9.2% year-on-year to INR 292.3 crores. The company also experienced a 49% decline in net profit, reaching INR 29.8 crores, and EPS fell to INR 2.41.

Archean Chemical has announced that the record date for a dividend of INR 2 per share is set for June 5, 2026. If approved, the payment will be made by July 11, 2026, marking the end of their fiscal year 2026.

Archean Chemical reported a 14% year-on-year decrease in Q4 revenue, with earnings dropping to ₹3 billion compared to ₹3.5 billion last year. This suggests a dip in quarterly sales figures.

Archean Chemical announces its board meeting on May 11, 2026, to endorse the financial results for FY26. Additionally, a decision regarding dividend distribution and the closing of trading windows is expected by May 13, 2026.

India's semiconductor industry targets a substantial growth of Rs 10 lakh crore by 2030, propelled by government backing and investments. Archean Chemical is shifting focus to the semiconductor sector, teaming up with UK technology for a SiC fabrication plant utilizing zinc bromide patents.